More birth defects lawsuits filed against Zoloft makers
February 23, 2012
Pharmaceutical
More lawsuits have been filed against drug maker Pfizer by women who claim that the company hid information that showed using the antidepressant Zoloft during pregnancy could cause birth defects. The class action lawsuit was filed in St. Louis Circuit ... Read More
FDA panel recommends approval of controversial diet drug Qnexa
February 23, 2012
Pharmaceutical
A new diet drug may soon be available for people battling the bulge, but it may come at a price. This week, a Food and Drug Administration (FDA) advisory panel reviewed clinical data on the weight loss drug Qnexa and ... Read More
BP, Anadarko will pay civil penalties for oil spill, judge rules
February 23, 2012
Environmental
BP and minority partner Anadarko Petroleum Corp. will have to pay civil penalties for violations of the Clean Water Act that led to the massive Gulf of Mexico oil spill, U.S. District Judge Carl Barbier, who is presiding over BP ... Read More
Memo reveals DePuy knew its hip implants were defective but continued to sell them
February 23, 2012
Pharmaceutical
Top executives for Johnson & Johnson subsidiary DePuy Orthopaedics had evidence that one of the company’s all-metal artificial hip devices was failing prematurely in patients a year before the device was recalled, but withheld this information and continued to market ... Read More
Consumer group lobbies for stricter oversight of medical devices
February 23, 2012
Pharmaceutical
Consumers Union (CU) is joining the fight to urge lawmakers to require stricter oversight of medical devices, especially since it says the current practice puts consumers, especially senior citizens, at risk for ongoing complications. CU is a nonprofit consumer watchdog ... Read More
Gulf states are one step closer to acquiring BP oil-spill fines
February 23, 2012
Environmental
Legislators from the Gulf States are one step closer to making sure billions of dollars in oil-spill fine money collected from BP’s violations of the Clean Water Act will go to the Gulf Coast states rather than into the federal ... Read More
FDA considers approval of diet drug despite birth defects, heart risks
February 23, 2012
Pharmaceutical
Drug maker Vivus Inc., is hoping to win Food and Drug Administration (FDA) approval for its diet drug Qnexa this week after a rejection in 2010 due to serious health concerns. Experts say the chances of the weight loss drug ... Read More